InflaRx N.V.

IFRX · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.2B · 65 employees

160

SEC Filings

$1.78

Close 2026-08-04

Employees

Business Summary

InflaRx N.V. is a clinical-stage biopharmaceutical company focused on developing anti-inflammatory therapeutics targeting the complement system. Its lead product candidate is izicopan (formerly INF904), and it has received Emergency Use Authorization in the U.S. and market authorization in Europe for GOHIBIC (vilobelimab) for treatment of severe COVID-19. The company also has IFX002 in its pipeline and is exploring vilobelimab for additional inflammatory indications including ulcerative pyoderma gangrenosum (PG).

Latest Stock Quote

IFRX 2026-08-04 $1.78 O:$1.79 H:$1.8777 L:$1.72 Vol:0.9M VWAP:$1.7613

origin leaf: null

160 total filings indexed. 160 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Company Identity

CIK	0001708688
Ticker	IFRX
Exchange	Nasdaq
SIC	2834: Pharmaceutical Preparations
Incorporated	P7
Website	https://www.inflarx.de
Listed	2017-11-08

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote AI Readiness Report

  Origin Provenance

  page leaf: aad03a8805bfb0a8db6493e13a4c8a02c276588e3807c2a666939cf47ff0ae9f

  parent: root

  content hash: 635166a98bd74dc23186d98dac50dac3fda1eee3f410df4440b346f8726fc86b

  signed: 2026-08-10T19:03:42.113Z

  sources: 0 verified data leaves

  chain: SEC.gov PEM → origin.rootz.global extraction → this page

  verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up IFRX using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on IFRX, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/IFRX (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.